Send to printer »

Insight & Intelligence™ : Dec 27, 2013

China’s In Vitro Diagnostics Marketplace, Part I

Although China has a vibrant domestic CLIA sector, the country’s MDx market is expanding rapidly and opportunities abound.
  • Enal Razvi

This GEN Report Provides a Snapshot of the China In vitro Diagnostics Marketplace based on Primary Market Analysis

  • Infectious Disease Testing Contributes to the Bulk of this Space Currently—with Few Disease Classes Dominating Revenue Generation Today
  • The Field is Fragmented with Thousands of End-User Laboratories where Testing is Performed
  • Both Local as well as Multinational Companies are Active in this Marketplace
  • Oncology Testing Represents a Future Growth Opportunity for this Marketplace and Offers Entry Opportunity to Technology Providers to Establish Partnerships with Local Companies to Participate in this Growth

 Click here to download this PDF report